Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receivin
- PDF / 365,512 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 116 Downloads / 193 Views
CORRECTION
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study Luca Faloppi1,2 · Marco Puzzoni2 · Andrea Casadei Gardini3 · Nicola Silvestris4 · Gianluca Masi5 · Giorgia Marisi3 · Caterina Vivaldi5 · Cosmo Damiano Gadaleta4 · Pina Ziranu2 · Maristella Bianconi6 · Cristian Loretelli7 · Laura Demurtas2 · Eleonora Lai2 · Riccardo Giampieri8 · Eva Galizia1 · Paola Ulivi9 · Nicola Battelli1 · Alfredo Falcone5 · Stefano Cascinu10 · Mario Scartozzi2,11 Published online: 10 November 2020 © Springer Nature Switzerland AG 2020
Correction to: Targeted Oncology (2020) 15:115–126 https://doi.org/10.1007/s11523-020-00698-x
Faloppi L, Puzzoni M, Casadei Gardini A, Silvestris N, Masi G, Marisi G, et al. Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carci‑ noma Receiving Sorafenib: The ALICE‑2 Study. Targeted Oncology. 2020;15:115-126 Page 115 and 126: The listing of the author names and affiliations, which previously read: “Luca Faloppi 1,2, Marco P uzzoni 2, Andrea Casadei 3 4 G ardini , Nicola S ilvestris , Gianluca M asi 5, Giorgia Marisi3, Caterina Vivaldi5, Cosmo Damiano Gadaleta4, Pina Ziranu2, Maristella B ianconi6, Cristian L oretelli7,
Laura Demurtas2, Eleonora L ai2, Riccardo G iampieri8, Eva 1 3 1 Galizia , Paola U livi , Nicola B attelli , Alfredo F alcone5, 9 2,10 Stefano Cascinu , Mario Scartozzi 1
Medical Oncology Unit, Macerata General Hospital, ASUR Marche AV3, Macerata, Italy
2
Medical Oncology Unit, University Hospital and Univer‑ sity of Cagliari, Cagliari, Italy
3 4
Medical Oncology Unit, IRCCS Giovanni Paolo II Cancer Center, Bari, Italy 5
The original article can be found online at https://doi.org/10.1007/ s11523-020-00698-x. * Mario Scartozzi [email protected] 1
Medical Oncology Unit, Macerata General Hospital, ASUR Marche AV3, Macerata, Italy
2
Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy
3
Medical Oncology Unit, IRCSS-IRST, Meldola, Italy
4
Medical Oncology Unit, IRCCS Giovanni Paolo II Cancer Center, Bari, Italy
5
Medical Oncology Unit, University of Pisa, Pisa, Italy
6
Medical Oncology Unit, San Benedetto del Tronto Hospital, ASUR Marche AV5, San Benedetto del Tronto, Italy
7
International Center for T1D, Department of Biomedical and Clinical Sciences, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi “L. Sacco”, University of Milan, Milan, Italy
Medical Oncology Unit, IRCSS-IRST, Meldola, Italy
Medical Oncology Unit, University of Pisa, Pisa, Italy
8
Oncology Department, Polytechnic University of Marche, Ancona, Italy
9
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy
10
Medical Oncology Unit, University of Modena, Modena, Italy
11
Oncologia Medica, Azienda Ospedaliera Universitaria Cagliari, Presidio Policlinico Universitario “Duilio Casula”, Km 4500 Bivio per Sestu, S.S. 5
Data Loading...
